Research & Insights
Latest News
Stay informed with the latest research insights, industry developments, and updates from our laboratory.
Metabolic Research3 min read
Retatrutide (LY3437943) Research Compound Profile: Molecular Architecture,
Retatrutide: The Future of Metabolic Health Exploring the science behind the triple-agonist candidate for obesity and diabetes. Read Latest Research Updates The treatment of obesity and type 2 diabetes is evolving rapidly, with retatrutide (LY3437943) emerging as a leading investigational compound. In March 2026, Eli Lilly reported positive topline results from its Phase 3 TRANSCEND-T2D-1 […]
Read Article
Metabolic Research3 min read
Retatrutide – What is Reta? – People who’ve seen the news about Phase 3 trial results wanting to learn more (informational)
Uncover Retatrutide, the investigational triple-agonist. Explore its unique science and potential for weight regulation and glycemic modulation in metabolic research.
Read Article